Blachawk and MindBio Now @Par!Further, under the Arrangement, the share capital of MindBio was amended to split the issued and outstanding MindBio Shares on a 1:2.61 split ratio (the "Split").
Following the closing of the Arrangement, MindBio has 78,252,003 MindBio Shares outstanding and has additionally reserved 3,378,461 MindBio Shares for issuance pursuant to the BLR Warrants.
Financings and Anticipated Listing Date
It is anticipated that on or about May 2, 2023, MindBio will close its non-brokered private placement of subscription receipts and issue common shares in connection with its previously announced private placements (the "Financings").
Further details in relation to such issuances will be disclosed in a subsequent press release to be issued upon completion of the private placements.
The New Blackhawk Shares will continue trading on the CSE under its current ticker symbol. It is anticipated that the MindBio will file its Form 2A listing statement with the CSE on or about May 2, 2023 and pending final approval from the CSE, MindBio Shares will commence trading on the CSE on or around May 5, 2023, under the ticker symbol "MBIO".
https://finance.yahoo.com/news/blackhawk-mindbio-therapeutics-corp-formerly-110000500.html
1:2.61
https://www.stockwatch.com/Quote/Detail?C:MBIO
C:MBIO - MindBio Therapeutics Corp
13:50:16M 0.04 13,000 1 Anonymous7 TD Sec
13:50:16C 0.035 -0.0052,0007 TD Sec7 TD SecK
MindBio 0.035
Blackhawk 0.015 × 2.61= 0.039
Glta!